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Resumen
Introducción: el estado nutricional y la evolución del virus de inmunodefi ciencia humana (VIH) están interconectados. A pesar de que algunos 
estudios hayan visto el impacto del estado nutricional en la calidad de vida (CdV) en pacientes con enfermedades crónicas, pocos han estudiado 
sus efectos en pacientes infectados de VIH. 
Objetivo: investigar la relación entre el estado nutricional y la CdV en adultos recientemente diagnosticados de VIH.
Métodos: cumplieron los criterios de inclusión los individuos diagnosticados de VIH en los 14 meses previos a una visita al hospital central de 
Lisboa. El estado nutricional fue evaluado por antropometría, análisis de la composición del cuerpo, y dieta, mientras que la CdV fue evaluada 
usando el cuestionario WHOQOL-HIV-BREF. También fueron considerados los datos sociodemográfi cos y clínicos.
Resultados: fueron seleccionados 51 individuos, la mayoría de sexo masculino, caucásicos, empleados, solteros y en tratamiento antirretroviral 
de gran actividad (TARGA). Varias características sociodemográfi cas, como el nivel de educación, la edad, el sexo y el estado de salud actual, 
fueron importantes indicadores del nivel de CdV (p < 0,05). Se observaron niveles de CdV más bajos en individuos con dietas inadecuadas, 
pérdida de peso comprobada y elevado perímetro de cintura en análisis bivariado (p < 0,05). Las mismas variantes infl uenciaron negativamente 
la CdV tras haber ajustado los factores de confusión en análisis multivariado (p < 0,05).
Conclusión: varios aspectos del estado nutricional infl uyeron en las variaciones observadas en la CdV, lo que sugiere que una intervención a 
nivel nutricional podría mejorar potencialmente la calidad de vida en esta población.
Abstract
Introduction: Nutritional status and the progression of the human immunodefi ciency virus (HIV) are interlinked; though some studies have looked 
at the impact nutritional status has on quality of life (QoL) in patients with chronic diseases, few have studied this in HIV-infected individuals.
Objective: To investigate the relationship between nutritional status and QoL in adults with a recent HIV diagnosis.
Methods: Individuals with an HIV diagnosis performed in the fourteen months prior to a medical visit to one of Lisbon’s central hospitals were 
eligible. Nutritional status was assessed by anthropometry, body composition analysis, and dietary intake. QoL was assessed using the WHOQOL-
HIV-BREF questionnaire. Sociodemographic and clinical data were also considered.
Results: Fifty-one subjects were eligible for enrolment; the majority were male, Caucasian, employed, single, and under highly active antiretroviral 
therapy (HAART). Lower QoL scores were observed in subjects with inadequate energy intakes, reported weight loss, and a high waist circum-
ference in bivariate analysis (p < 0.05); the same variables infl uenced QoL negatively after adjusting for confounders in multivariate analysis 
(p < 0.05). Various sociodemographic characteristics such as level of education, age, gender, and current health problems also predicted QoL 
signifi cantly (p < 0.05).
Conclusion: Various aspects of nutritional status were responsible for the variations observed in QoL, suggesting a potential for nutritional 
intervention in improving QoL in this population.
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INTRODUCTION
Nutrition has always played a role in human immunodeficien-
cy virus (HIV) care, but changes in the disease pattern, a fall in 
mortality rates, and hence a longer life expectancy, have led to 
changes in the goals nutritional support in this population (1). This 
has drove attention to quality of life (QoL) as an important health 
care indicator, given the chronicity of the disease (2). QoL is influ-
enced by “physical health, psychological state, level of indepen-
dence, social relationships, personal beliefs and their relationship 
to salient features of their environment”, according to the World 
Health Organization (WHO) (3). A better QoL has been observed 
in healthy populations compared to patients with chronic diseas-
es (4,5). The relationship between nutrition, QoL and immune 
dysfunction, such as that seen in HIV, is interconnected (1); the 
disease progression is associated with a decline in nutritional sta-
tus and immune function, even during highly active antiretroviral 
therapy (HAART) (6). However, a decline in nutritional status alone 
can also weaken the immune system and hence, increase the risk 
of infection and mortality (1,7). Malnutrition and HIV therefore 
have a negative effect on each other by acting synergistically 
on the immune system, and consequently affecting QoL (7). It is 
important to understand the impact nutritional status has on these 
patients’ physical and mental health (3), since they are known 
to predict QoL. In the general population, lower anthropometric 
measurements are not only associated with a lower QoL, but being 
overweight or obese and having a high waist circumference have 
also been associated to morbidity and an impaired QoL (8).
Like with any other chronic disease, the risk for malnutrition 
in HIV is high (9) and, therefore, it is fundamental to assess the 
nutritional status of this population at regular intervals. Although 
it is well established that an improved nutritional status results in 
a better QoL in certain chronic diseases (10), this relationship is 
still unclear in HIV. Studies on this topic are scarce especially in the 
western world (1,11-13). Outside Europe, some have suggested a 
good nutritional status to improve QoL in HIV-infected individuals 
(1). Lower anthropometric measurements have been correlated 
with a lower QoL (11).
Nutritional status could have a positive impact on QoL by assisting 
in symptom management (11), improving HAART absorption and 
tolerance, and delaying the progression of HIV (14). The impact nutri-
tional status has on QoL in HIV patients needs to be further explored 
to potentially tailor nutritional support to achieve gains in QoL.
The aim of this study was to investigate the impact nutritional 
status has on QoL in a sample of HIV-infected adult patients. 
Sociodemographic and HIV clinical-related variables were also 
considered.
MATERIALS AND METHODS
SUBJECTS
The sample included outpatients followed at one of Lisbon's 
central hospitals (for their HIV appointment). Those previously 
identified from clinical records as having a recent HIV diagnosis 
were eligible for enrolment. On the day of the visit, they were 
asked if they were willing to participate in the study; they were 
given a brief explanation describing the purpose of the study and 
what it involved, and the right to refuse to participate. Eligible 
subjects included: a) patients who had tested positive for HIV 
in the 14 months prior to the start of the study; b) those who 
were followed at the hospital for the first time in 2015 or 2016; 
and c) subjects who agreed to participate in the study. Data was 
collected between the 4th of January and the 1st of April 2016. 
Exclusion criteria included: a) subjects under eighteen years of 
age; b) pregnant women; c) subjects who did not respond to 
the WHOQOL-HIV-BREF questionnaire; and d) those who did not 
speak Portuguese or English.
SOCIODEMOGRAPHIC AND CLINICAL DATA
Sociodemographic data collected included gender, age, race, 
level of education, employment status, and marital/relationship 
status. Regarding clinical data, date of diagnosis, year of infection, 
mode of transmission, HAART regimen (yes/no), HIV single tablet 
regimen (yes/no), past opportunistic infections, current medication, 
medical history, current problems, current drug use (yes/no), and 
physical activity (yes/no) were recorded. Subjects under HAART for 
one month or less were considered to be naïve to therapy.
NUTRITIONAL STATUS ASSESSMENT
Nutritional status was assessed by: a) anthropometry; b) bio-
electrical impedance analysis; and c) dietary intake.
Anthropometric measurements considered were weight, height, 
triceps skinfold (TSF), waist circumference (WC), hip circumfer-
ence, body mass index (BMI), arm muscle area (AMA), and waist 
to hip ratio (W/H ratio). To quantify unintentional recent weight 
loss (if this information was not available from clinical records), 
subjects were asked about their weight history in the previous 
month. Weight was measured to the nearest kg with patients 
wearing light clothes and on bare foot using a calibrated scale, 
height to the nearest millimeter using a stadiometer, skinfold to 
the nearest 0.2 millimeter using a Harpenden caliper, WC and 
hip circumference to the nearest millimeter using a non-elastic 
measurement tape. TSF was measured at the mid-point between 
the acromion and the tip of the olecranon; WC, between the lowest 
rib and the iliac crest; and hip circumference, at the level of the 
anterior superior iliac spine at the end of a normal expiration. Male 
and female subjects with a WC ≥ 94 cm and ≥ 80 cm, and a W/H 
ratio ≥ 0.90 cm or ≥ 0.85 cm, respectively, were considered at 
risk for metabolic complications (15). Frisancho’s data (16) were 
used as references for TSF and AMA measurements. TSF and 
AMA were considered in terms of their (%) adequacy, obtained 
according to the following formula (17): TSF or AMA adequacy 
(%) = TSF obtained (cm) or AMA calculated (mm) x 100/50th per-
centile of TSF or AMA. Values ≥ 110% were considered as more 
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than adequate measurements; 90-110%, as adequate; and a 
measurement < 90% was considered as lower than adequate. 
Since Frisancho’s data is derived from a Caucasian population, a 
second analysis, excluding black subjects was performed when 
these variables were used.
Bioelectrical impedance analysis was performed using a sin-
gle-frequency analyzer (OMNRON BF350) to assess body fat per-
centage, and visceral fat; cut-off points for both measurements 
were used to classify the data (18,19).
To estimate dietary intake, a semi-quantitative Food Frequency 
Questionnaire (FFQ), validated for the Portuguese population, was 
used (20). The intake of macronutrients and micronutrients was 
analyzed continuously and in categories of intake to understand 
the adequacy of subjects’ nutrient intake; this was done for pro-
tein, calcium, iron, water soluble and fat-soluble vitamins. The 
following formula was used to calculate nutritional adequacy: % 
adequacy = (nutrient intake*100)/recommended daily allowance 
(RDA). Two designations were used to describe the adequacy of 
intake: inadequate (< 90% of requirements), and adequate/more 
than adequate (≥ 90% of requirements). Adequate intakes for 
protein were ≥ 1.2 g/kg/day. Adequate energy intakes were those 
within 25-35 kcal/kg/day and inadequate, those above or below 
the 25-35 kcal/kg range (21).
LABORATORY DATA
Only results that had been collected in the 30-day period prior 
to the assessment were considered. The following were collect-
ed: blood pressure, lymphocyte CD4 and CD8 count, viral load, 
hemoglobin, lipid profile, fasting glucose concentration, liver and 
kidney function tests, total proteins, albumin, C-reactive protein 
(CRP), blood serum concentrations of ions. CD4 count was divid-
ed into three categories, according to the Centers for Disease 
Control (22).
QoL ASSESSMENT
The Portuguese version of the WHO Quality of Life Question-
naire (WHOQOL- HIV-BREF) was used to assess the QoL of the 
study population (23). The psychometric properties of the ques-
tionnaire have been validated for its use in Portuguese people 
living with HIV. The instrument contains six domains to assess 
QoL: physical health, level of independence, psychological health, 
social relations, environmental health, and spirituality. Thirty-one 
items are used to construct the six domains. There is also a gen-
eral facet (General QoL), composed of two items, which examines 
QoL and health, in general (Q1 and Q2). All items are rated on 
a 5-point Likert scale; scores are scaled in a positive direction, 
where higher scores suggest a better QoL. Mean score of items in 
each domain were used to obtain the domain score. After comput-
ed, domain scores were transformed to a 0-100 scale to allow for 
comparison with the WHOQOL-100 instrument. The instrument’s 
Users’ Manual was used to score, code, check and clean data.
STATISTICAL ANALYSIS
The data collected was processed and analyzed using the IBM® 
SPSS® software, version 21. The internal consistency of the QoL 
instrument was measured with Cronbach’s alpha. Descriptive sta-
tistics such as mean and standard deviation were used to summa-
rize continuous data, and frequencies and proportions were used 
to summarize categorical variables. Parametric and non-paramet-
ric tests were used depending on variable distribution. Student’s 
t-test and analysis of variance (ANOVA) were used to investigate 
differences in mean QoL scores of dichotomous variables, and 
variables with more than two groups, respectively. The level of 
significance was set at p < 0.05 in this study. Relevant variables 
that were found to be significantly related (p < 0.05) with QoL in 
bivariate analysis were subjected into multivariable analysis using 
a stepwise forward model building strategy to understand the effect 
that each significant independent variable had on the association 
nutrition-QoL, with other independent variables remaining con-
stant. Outliers were excluded in multivariate analysis.
ETHICAL AND DEONTOLOGICAL 
CONSIDERATIONS
Ethical conditions were followed according to the Declaration of 
Helsinki, which ensured the informed voluntary participation and 
confidentiality of patient’s data. The permission to gather infor-
mation from patients registered at the hospital was obtained for 
a period of 12 weeks (starting on the 4th of January, 2016) by the 
director of the infectious diseases department. The study followed 
the hospital’s protocols with regard to access to medical records.
RESULTS
STUDY SAMPLE
There were 191 patients who visited the outpatient clinic for the 
first time in 2015; 20 were excluded before screening because 
they were identified in advance as having tested positive for HIV 
before November 2014, elsewhere. Considering the remaining 
171 potential eligible subjects in a year, a minimum of 43 sub-
jects would need to be included to be representative of the study 
period (12 weeks starting on the 4th of January, 2016). During the 
12-week study period, 53 subjects were screened; one subject 
was excluded because he was deaf, and another refused to par-
ticipate due to time constraint. Fifty-one subjects met the inclusion 
criteria for the study and were enrolled.
STUDY SAMPLE CHARACTERISTICS: 
SOCIODEMOGRAPHIC AND CLINICAL DATA
Patient characteristics are illustrated in table I. Mean age was 
41.1 years (± 14.2; range 21-74). Eleven subjects (21%) were 
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experiencing a current health problem; four had cancer (prostate, 
endometrial, Burkitt’s lymphoma, Kaposi sarcoma), and the others 
ranged from heart failure, rheumatic disease, osteomyelitis. More 
than half of patients had a past medical history (60%), such as 
diabetes (5.9%), hypertension (3.9%), hepatitis B or C (11.8%), 
cancer (7.8%), syphilis (7.8%) and respiratory infection (3.9%). 
The remaining included uveitis, asthma and heart failure (oppor-
tunistic infections not included here). Almost half the patients 
(45.0%) were taking some kind of medication besides HAART 
such as sleeping pills, antidepressants, antibiotics, oral antidia-
betic medication, antihypertensive drugs, or oral chemotherapy.
The mean CD4 and CD8 cell count was 522 cells/mm3 (± 
351; range 11-1,899) and 1,068.6 cells/mm3 (± 638; range 
113.5-2,942.0), respectively. The majority of patients (86%) had 
an inverted CD4:CD8 ratio (< 1). More than half had detectable 
viral loads (54.0%), and were under HAART (58.0%). The mean 
duration (in months) since HAART initiation was 7.8 months (± 
4.5; range 1-19), and six patients (11.8%) were on a single tab-
let regimen. HIV diagnosis took place in 2015 for most patients 
(68.6%). The majority (47.0%) had been either infected in the year 
prior to assessment (2015) or they did not know when it happened 
(39.2%), and the remaining, had been infected in 2014 (13.7%). 
Ten patients (20.0%) had experienced an opportunistic infection 
in the past. In one third of patients (31.4%) HIV transmission 
occurred in men who had sex with men (MSM).
NUTRITIONAL STATUS ASSESSMENT
Subjects’ anthropometric, body composition and nutrient 
intake data are illustrated in table II. One patient was under-
weight, according to BMI, most were normal weight (60.8%), and 
more than one third (37.3%) were overweight or obese. TSF and 
AMA were lower than adequate for 66.7% and for 33.3% of the 
sample, respectively. According to WC and W/H ratio, 20 (39.2%) 
and 16 (31.4%) subjects had a high metabolic risk, respectively. 
A similar proportion of patients had a healthy and a high body 
fat mass (41.2% and 47.1%, respectively), and the visceral fat 
of four subjects (8.0%) was above the ≥ 12% reference cut-off 
value (22). Only 25.5% of patients had adequate energy intakes 
(25-35 kcal/kg). Protein intakes were adequate for most subjects 
(82.4%). Folate and biotin intakes were inadequate for more than 
half of the study sample and one quarter had inadequate pan-
tothenic acid intakes. Less than five individuals (9.8%) had an 
inadequate intake of one or more of the remaining water-soluble 
vitamins (data not reported). Over 80% of the sample had inade-
quate intakes of vitamins D, E, and K. Vitamin A was the exception, 
where intakes were adequate for all, but two individuals.
LABORATORY DATA
Data was not available for every biomarker of each of the 51 
patients. Total cholesterol, LDL-c HDL-c, and triglycerides were 
measured in 31-35 individuals; 25.0% had levels above the ref-
Table I. Sociodemographic and clinical data
Socio demographic/Clinical variable n (%)
Gender 
 Male 38 (74.5)
 Female 13 (25.5)
Race
 Caucasian 38 (74.5)
 Black 13 (25.5)
Literacy
 < Secondary 21 (41.2)
 Secondary 6 (11.8)
 Tertiary 19 (37.3)
Marital status
 Single 31 (60.8)
 Married/In a relationship 18 (35.3)
Physical activity
 Yes 16 (31.4)
 No 35 (68.6)
Employment
 Working 31 (60.8)
 Not working 20 (39.2)
Current problem
 Yes 11 (21.6)
 No 40 (78.4)
Hospitalized in the last year
 Yes 16 (31.4)
 No 35 (68.6)
Medical history
 Yes 31 (60.8)
 No 20 (39.2)
Other medication
 Yes 23 (45.1)
 No 28 (54.9)
CD4 count
 < 350 17 (33.3)
 > 350 34 (66.7)
CD4/CD8 ratio (mean)
 > 1 7 (13.7)
 < 1 44 (86.3)
Viral load
 Detectable 28 (54.9)
 Undetectable 22 (43.1)
Opportunistic infection
 Yes 10 (19.6)
 No 41 (80.4)
HIV year diagnosis 
 2014 10 (19.6)
 2015 35 (68.6)
 2016 5 (9.8)
Infection route
 Heterosexual 35 (68.6)
 MSM 16 (31.4)
HAART
 Yes 30 (58.8)
 Naive 21 (41.2)
Single tablet HAART regimen
 Yes 6 (11.8)
 No 24 (47.1)
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erence interval for total cholesterol, 78.8% were not within the 
reference range for HDL-c, only one individual had an abnormal 
LDL-c, and 17.6% had elevated triglycerides. Hepatic function 
indicators, ALT, AST, GGT, and bilirubin levels were measured 
in 39, 47, 31, and 34 subjects, respectively; less than half of 
subjects had inadequate levels of any one of these biomarkers. 
Hemoglobin was within a healthy range for 26 (63.0%) individuals 
out of a total of 41 measured. From the 43 values available for 
blood glucose, eight subjects (18.6%) had elevated levels. Other 
biomarkers such as total proteins, albumin, kidney function, were 
not considered as relevant since they were only available for a 
small number of individuals (< 14).
QUALITY OF LIFE
The internal consistency of the WHOQOL-HIV-BREF using Cron-
bach’s alpha coefficient, was > 0.7 for all six domains, and for 
General QoL, it was 0.6. Table III illustrates patient’s mean QoL 
scores for each domain and for general QoL. When considering 
the mean scores of all subjects, the lowest scores observed were 
those for general QoL (61.3 ± 18.8), followed by physical health 
(63.2 ± 21.5). The highest scores were observed for the level of 
independence (72.1 ± 20.2).
SOCIODEMOGRAPHIC AND CLINICAL DATA
Table III illustrates results from bivariate analysis of sociode-
mographic, clinical and nutritional data with QoL. Gender, edu-
cation level, infection route, current health problem, and physical 
activity were shown to be significantly different across three or 
more QoL dimensions. Significant differences in QoL according to 
education level were only observed between individuals without 
secondary education, and those with a tertiary level of education, 
after multiple comparison tests. QoL scores were significantly 
different across the different employment, race, medical history, 
transmission mode and CD4 lymphocyte categories in one or two 
dimensions. The significant differences observed in CD4 lympho-
cyte count were between the lowest and highest class. Age was 
negatively and significantly correlated to the level of independence 
(r = -0.3, p = 0.028). No other significant differences in QoL 
scores across the different sociodemographic (marital status/rela-
tionship) or clinical variables (hospitalized in the last year, HAART 
status, duration of infection, duration of HAART, viral load, history 
of opportunistic infections, HAART single-tab regimen, CD4/CD8 
ratio) were observed.
NUTRITIONAL STATUS AND QoL
The QoL of patients, according to nutritional status, is illustrated 
in table III. There was only one subject who was underweight, 
and he was excluded when testing BMI. Only two classes were 
compared (normal weight and overweight/obesity). 
Table II. Nutritional status of study sample
Nutritional parameter n (%)
BMI (kg/m2)
 Normal weight 31 (60.8)
 Overweight/obese 19 (37.3)
Waist Circumference (cm)
 Risk 20 (39.2)
 No risk 29 (56.9)
W:H ratio
 Risk 16 (31.4)
 No risk 32 (62.7)
% Adeq TSF thickness
 Lower than adequate 34 (66.7)
 Adequate 6 (11.8)
 ≥ Adequate 11 (21.6)
% Adeq AMA 
 Lower than adequate 17 (33.3)
 Adequate 10 (19.6)
 ≥ Adequate 24 (47.1)
Fat mass  (%)
 Under fat 5 (9.8)
 Healthy 21 (41.2)
 Over fat 24 (47.1)
Visceral fat (%)
> 12% 4 (7.8)
< 12% 45 (88.2)
Weight loss ≥ 1 kg
 Yes 14 (26.9)
 No 21 (40.4)
Energy (kcal) 
 Inadequate 38 (74.5)
 Adequate (25-35 kcal/kg) 13 (25.5)
Protein (g)
 Inadequate 9 (17.6)
 ≥ Adequate  42 (82.4)
Folate (µg)
 Inadequate 16 (31.4)
 ≥ Adequate  35 (68.6)
Vitamin A Tot (µg)
 Inadequate 2 (3.8)
 ≥ Adequate 49 (94.2)
Vitamin D (µg)
 Inadequate 51 (100)
 ≥ Adequate 0 (0)
Vitamin E (mg)
 Inadequate 44 (84.6)
 ≥ Adequate 7 (15.4)
Vitamin K (µg)
 Inadequate 50 (98.1)
 ≥ Adequate  1 (1.9)
BMI: Body mass index; W:H: Waist:hip.
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No significant differences in QoL scores were observed across 
the different categories of BMI, % TSF adequacy, W/H ratio, % 
body fat, and protein intake. As a continuous variable, % body fat 
was inversely associated with general QoL (r = -0.4, p = 0.010), 
psychological health (r = -0.3, p = 0.043), and borderline sig-
nificantly associated with level of independence (r = -0.3, p = 
0.064). Significant differences in QoL scores were found across 
the different categories of waist circumference, % AMA adequacy, 
unintentional weight loss, and energy intake (Table III). The mean 
psychological domain score was significantly different across the 
three different AMA classes (lower than adequate, adequate, more 
than adequate); a second analysis, comparing the lower and higher 
AMA class, showed that the difference remained significant in the 
psychological domain, and in addition, became significant in the 
social domain, where higher QoL scores were observed in the 
lower (lower than adequate) AMA class. Excluding black subjects 
from analysis did not affect the results of the variables using ref-
erence percentiles for Caucasians. As a continuous variable, % 
AMA was correlated with general QoL (r = 0.3, p = 0.033), psy-
chological health (r = -0.4, p = 0.010), and social relationships (r 
= -0.3, p = 0.042). QoL scores across the different energy intake 
categories are shown in table III. The 13 subjects with adequate 
energy intakes (25-35 kcal/kg) rated their general QoL significantly 
higher compared to subjects with inadequate intakes. Individuals 
consuming ≥ adequate protein intakes, compared to those with 
inadequate intakes, did not differ significantly in QoL scores. Only 
two individuals had inadequate iron intakes and therefore results 
were not considered to be relevant (data not shown). Vitamin K and 
D intakes were not tested for the same reason. The correlations 
with other micronutrients were not significant (data not show). 
Higher alcohol intakes were associated to significant lower scores 
in environmental health (r = -0.3, p = 0.028).
LABORATORY RESULTS AND QoL
Hemoglobin level was significantly correlated to general QoL (r 
= 0.4, p = 0.013), physical health (r = 0.5, p < 0.001), psycho-
logical health (0.4, p = 0.027), level of independence (r = 0.5, p 
= 0.001), social health (r = 0.4, p = 0.011), and environmental 
health (r = 0.4, p = 0.028). CRP (only analyzed 14 patients) cor-
related moderately with the level of independence (r = -0.5, p = 
0.157). AST correlated negatively and significantly with physical 
health (r = -0.4, p = 0.023). The remaining biochemical bio-
markers measured did not correlate significantly with QoL and 
were not reported.
MULTIVARIATE ANALYSIS
Variables that were significant in bivariate analysis (age, gen-
der, race, employment status, education level, medication, med-
ical history, current health problem, CD4 count, % AMA, weight 
loss that was unintentional, WC, energy intake, alcohol intake, 
hemoglobin) were subjected into multivariate analysis. Table IV 
illustrates the results of the multivariate analysis. The regression 
model explained between 31.0% and 52.2% of the variance in the 
different domains. No significant predictor for the spiritual domain 
was identified. After adjusting for the different confounders, inade-
quate energy intakes, an unhealthy WC, a ≥ adequate AMA (versus 
lower than adequate), and unintentional weight loss were found to 
be significantly associated with lower QoL scores. WC and energy 
intake were the strongest determinants of general QoL. A lower % 
AMA adequacy and weight loss were the strongest determinants 
of psychological health. Energy was associated with general QoL 
(p < 0.01), and level of independence (p = 0.025); weight loss 
was associated with psychological (p = 0.02) and environmental 
health (p < 0.01). In multivariate analysis, physical activity only 
predicted QoL in social relationships, hemoglobin predicted social 
relationships and physical health (p < 0.05), and non-antiretrovial 
medication predicted patients’ level of independence (p < 0.05). 
Education and current health problems influenced most of the 
QoL domains significantly.
DISCUSSION
As far as our knowledge extends, this is the first study inves-
tigating the relationship between nutritional status and QoL in 
HIV-infected individuals in Europe. QoL is affected by culture and 
level of economic development, which explains why developing 
countries report poorer QoL outcomes compared to developed 
countries; as a result, extrapolation of other studies findings 
must be carefully made. Although the relationship between HIV 
and malnutrition has been studied, few have looked at QoL as a 
consequence of the synergy between these two (1,11-13). This 
study involved 51 subjects with a relatively recent HIV diagnosis; 
the majority were Caucasian, male, employed, and had finished 
secondary school. More than half were under HAART, of which 
more than one third had detectable viral loads. Compared to the 
QoL of participants enrolled in the validation of the Portuguese 
WHOQOL-HIV-BREF, with the exception of physical health, the 
scores of all QoL dimensions were higher in this sample, inde-
pendent of disease stage (23). Our study only involved patients 
with a recent HIV diagnosis, which probably explains the better 
QoL outcomes compared to the former study, since patients with 
an advanced stage of the disease present a lower QoL (24). In 
line with most studies reporting gender inequalities in QoL in this 
population (25), men reported higher scores in QoL compared 
to women across most dimensions, although in multivariate 
analysis gender was only associated with environmental health. 
Consistent with previous research (26,24), the present findings 
indicate that subjects with higher education have an enhanced 
QoL across all domains, compared to those who did not complete 
secondary education. A higher education and income have been 
associated to better coping strategies (24), which may explain 
the difference in scores. Similar to previous findings (27), this 
study did not detect significant differences in QoL among sub-
jects who were married/in a relationship, compared to single 
subjects. In this study MSM were significantly more satisfied 
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with their environment compared to heterosexuals; this could 
be related to the social support groups they are part of, which 
have shown to be inversely related to rates of depression (28). 
Patients who were currently ill reported significant lower scores 
in various domains, which is consistent with most QoL-related 
works in HIV subjects (29,30). Although evidence is conflicting, 
significant differences among QoL domains with stages of HIV 
infection have been reported (12,24); similarly, in this study, the 
level of independence was significantly superior in subjects with 
CD4 counts > 500 compared to those with < 200. Despite the 
absence of significance, patients under HAART had worst QoL 
outcomes compared to naïve-treatment patients. This finding is 
in agreement with results of a cross-sectional study (24) where 
lower scores in all domains were observed in patients in the first 
year of HAART, compared to naïve patients; the QoL of those who 
were being treated for more than one year, however, was better 
than for those in the first year of treatment, and this has been 
documented elsewhere too (12). Again, despite the absence of 
significance, those under HAART for a longer time had higher QoL 
scores across all domains compared to subjects under treatment 
for a shorter period. This could be related to the side effects 
of treatment experienced at the start of HAART (12). Patients 
switching to a HAART single-pill fixed dose regimen in an Italian 
trial experienced non-significant improvements in QoL (29); in 
the present investigation QoL was better in subjects on a sin-
gle-pill regimen (p > 0.05). The present study reports improved 
QoL scores for patients who were physically active compared to 
those who were not, in most dimensions. Physical activity and 
nutrition counselling contributed to significant improvements in 
QoL, nutritional status and clinical parameters in a trial (31) and 
Table IV. Multivariate analyses: linear regression models to identify QoL predictors
Independent predictors for each dependent 
variable
Beta R2a F p-value
General QoL 52.2%
 WC -13.629 12.242 0.001
 Energy 13.158 9.699 0.003
 Education -11.998 9.141 0.004
 Current problem -8.367 3.046 0.088
Physical health 31.0%
 Education -12.695 6.331 0.016
 Hb 3.924 5.811 0.020
 Current problem -12.949 4.240 0.046
 Medical history -10.066 4.068 0.050
Psychological health 32.2%
 AMA 13.972 11.119 0.002
 Weight loss -11.739 5.652 0.022
 Education -9.267 4.687 0.036
Level of independence 57.5%
 Education -13.943 12.838 0.001
 Current problem -16.028 9.240 0.004
 Medication -10.542 7.191 0.011
 Energy 9.707 5.497 0.025
Social relationships 55.5%
 Physical activity 12.899 10.220 0.003
 Hb 3.899 9.601 0.004
 Age -0.248 4.404 0.045
Environment 50.9%
 Gender -11.236 10.304 0.003
 Weight loss -12.918 9.677 0.004
 Education -9.598 8.119 0.007
Spirituality No significant predictor identified
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in another study moderate physical activity was associated with 
physical, psychological and immunological benefits (32).
This study did not find significant variations in QoL with 
BMI class, in contrast to other works involving HIV patients 
(1,11,12). However, only two classes of BMI were compared, 
due to the absence of underweight and obese class I-III sub-
jects enrolled in the study. The poor psychological outcome 
observed in patients with unintentional weight loss in this study 
is in agreement with former findings (24). The fact that weight 
loss is an important marker of disease progression and symp-
tom status may help explain these results. Also, alterations in 
body image significantly impact on psychosocial wellbeing and 
QoL (33), suggesting different aspects influencing psycholog-
ical outcome.
In this study, a moderate-high WC was a significant contributor 
to a worst outcome in general QoL; this is strongly associated 
to a poor QoL (34). Exercise has been shown to reduce WC in 
HIV-patients (35); therefore, there may be a role for exercise as a 
potential strategy to improve nutritional status and, consequently, 
QoL (31,35). In contrast to the limited available evidence on AMA 
and QoL suggesting a positive relationship between the two (36), 
an inverse relationship was found in the present study, where the 
lowest QoL scores were observed in subjects with ≥ adequate 
AMA measurements (though similar scores were observed for 
lower than adequate and adequate categories). Heymsfield et al. 
(37) showed that the equation for calculating AMA overestimated 
it by 25%; this could mean that part of the subjects who were 
found to exceed AMA adequacy (47.1%) in this study could actu-
ally have adequate measurements, and this could have led to 
the confusing interpretation of results. In this study, lower QoL 
scores, particularly in general QoL and psychological health, were 
observed in subjects with higher body fat percentages. The asso-
ciation between body fat percentage and QoL in this population 
has not been well documented to date, but higher percentages of 
body fat were associated to lower QoL scores observed in other 
chronic disease patients (38).
When weight maintenance is the goal, energy requirements 
should match energy expenditure; however, the latter is poorly 
understood in chronic disease such as HIV (39). In this study, 
intakes ranging 25-35 kcal/day were considered as normal and 
subjects within this range of intake had better QoL outcomes for 
general QoL.
Biochemical markers did not play a significant role in predicting 
QoL in this study with the exception of hemoglobin. The strong 
correlations found are consistent with previous findings (40) where 
improvements in hemoglobin translated into significant improve-
ments in QoL.
Deterioration in nutritional status and the associated chang-
es in muscle, immune, and cognitive function observed in other 
populations (41) probably explain the decline in physical, mental, 
and environmental performance observed in this work and others 
investigating nutrition and QoL. Similar to the present work, which 
reports nutritional status to explain over one third of the vari-
ance in QoL, regression analysis in other works with chronically 
ill patients determined that > 25% of the variation change in QoL 
was explained by changes in nutritional status (38,42). Correct-
ing the energy density of the diet, becoming physically active, 
achieving a healthy body composition, and preventing uninten-
tional weight loss could lead to improvements in QoL, according 
to the findings reported in this study.
STRENGTHS AND LIMITATIONS
Despite the small number of individuals enrolled in this study, 
all nutritional parameters associated with QoL in bivariate analysis 
remained significant in multivariate analysis, implying that differ-
ent aspects of nutritional status are likely to have a reasonable 
impact on different QoL dimensions. Due to the heterogeneous 
characteristics of HIV patients, this study only focused on patients 
with a recent HIV diagnosis to prevent further confounding of the 
data. This means that findings should carefully be extrapolated to 
the different stages of HIV infection.
Although the use of a FFQ relies on long-term memory and does 
not take into account the intake of foods from different ethnic/
racial groups, a population validated FFQ was used in this work; 
other methods are unable to describe the usual diet, or are very 
time consuming.
Although the occurrence of physical activity was recorded, 
details on the nature of the exercise performed could have helped 
understand the type of exercise necessary to achieve beneficial 
outcomes in QoL.
Accurate individual nutritional requirements are dependent 
on stage of infection, HAART status, nutritional status, HIV-re-
lated symptoms, and many others. Equations to calculate ener-
gy requirements were not used since activity factors were not 
recorded. By establishing a large range of adequate energy intake 
(25-35 kcal/kg), or a minimum adequate intake for protein (1.2 g/
kg), with the intention to cover the requirements of all individuals, 
is not sufficiently accurate to determine how far requirements 
are being met.
CONCLUSION
This study found worst QoL outcomes with inadequate ener-
gy intakes, presence of unintentional weight loss, and a moder-
ate-high waist circumference. QoL was higher in subjects under-
going physical activity. Despite clinical and sociodemographic 
patient characteristics having shown to be significant predictors 
of QoL in this population, with advances in HIV treatment and 
prolonged survival times, finding strategies to maximize QoL such 
as integrating nutrition advice and exercise into HIV-treatment 
plans could serve as simple, cost-effective tools with the poten-
tial to improve or prevent the occurrence of events that have 
been shown to deteriorate QoL. More studies involving on-going 
nutritional and QoL assessment in HIV patients are required to 
understand the long-term impact therapeutic, dietary and life-
style modifications have on the different QoL dimensions in this 
chronically-ill population.
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